CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Rachael Morton

OPENALEX: A5034982958↗ORCID: 0000-0001-7834-0572↗

Affiliations

Organizations

Cooperative Trials Group for Neuro-Oncologyauthorship · AU National Health and Medical Research Councilauthorship · AU Respiratory Clinical Trialsauthorship · AU The University of Sydneyauthorship · AU

Public evidence

1 connected articles

Oral cannabinoid-rich THC/CBD cannabis extract for secondary prevention of chemotherapy-induced nausea and vomiting: a study protocol for a pilot and definitive randomised double-blind placebo-controlled trial (CannabisCINV).2018 · Europe PMC

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Rachael Morton - Medical Cannabis Research Engine